Skip to main content
. 2020 Jul 13;12(7):1880. doi: 10.3390/cancers12071880

Figure 5.

Figure 5

Muscle proteomic profile in all experimental groups subject or not to leucine-rich diet and bearing or not Walker-256 tumour. (a) malate dehydrogenase cytoplasmic—Mdh1, accession code O88989 and (b) malate dehydrogenase mitochondrial—Mdh2, accession code P04636 in gastrocnemius muscle under effects of Walker-tumour development and nutritional supplementation with leucine. (c) Glycogen phosphorylase—Pygm, accession code P09812 and (d) Pyruvate dehydrogenase E1 component—Pdhb, accession code P49432 in gastrocnemius muscle. (e) Phosphoglucomutase-1—Pgm1, accession code P38652 in gastrocnemius muscle. The values are expressed as the difference of maximal fold change. Legend: C, control group; W, Walker tumour-bearing group; L, rats fed a leucine-rich diet; WL, tumour-bearing rats fed a leucine-rich diet. * p < 0.05 difference against C group; ** p < 0.05 difference against L group: # p < 0.05 difference against WF group.